title: Developmental regulation of flavin-containing monooxygenase (FMO) isoforms 1 and 2 in pregnant rabbit.
abstract: Mammalian flavin-containing monooxygenase (FMO, EC 1.14.13.8) metabolizes a vast number of structurally diverse xenobiotics containing a soft-nucleophile, typically a nitrogen or sulfur. FMO is not inducible by the classical cytochrome P450 (CYP) inducers, such as phenobarbital, polycyclic aromatic hydrocarbons, ethanol or macrolide antibiotics. Evidence does exist from a number of laboratories, however, for developmental and hormonal regulation of FMO. Our laboratory has confirmed previous observations of enhanced FMO activity during mid- and late-gestation in maternal rabbit lung and have demonstrated that this response is due to increased protein and catalytic activity associated with FMO2. The time course of expression of FMO2 during mid- and late-gestation correlates to plasma peaks of progesterone or cortisol. FMO2 also peaks at parturition in maternal kidney, coincident with plasma cortisol levels. FMO2 is induced by s.c. administration of either progesterone or dexamethasone in lung, or by dexamethasone in kidney. Correlation of plasma progesterone or cortisol levels during gestation and postpartum support a role for progesterone, but not cortisol in regulation of FMO2 in maternal rabbit lung. The levels of FMO1 also appear to be increased during mid- and late-gestation in liver. FMO1 in liver may also be regulated during gestation by progesterone or glucocorticoids as administration of these steroids enhanced FMO1 mRNA levels 4-fold.
authors.affiliation: Toxicology Program, Oregon State University, Corvallis, USA.
authors.forename: M Y
authors.initials: MY
authors.lastname: Lee
authors.forename: S
authors.initials: S
authors.lastname: Smiley
authors.forename: S
authors.initials: S
authors.lastname: Kadkhodayan
authors.forename: R N
authors.initials: RN
authors.lastname: Hines
authors.forename: D E
authors.initials: DE
authors.lastname: Williams
mesh_terms: D000818:Animals; D015153:Blotting, Western; D003907:Dexamethasone / Q000008:administration & dosage / Q000494:pharmacology; D004790:Enzyme Induction / Q000187:drug effects; D005260:Female; D005415:Flavins / Q000378:metabolism*; D018507:Gene Expression Regulation, Developmental / Q000235:genetics; D007668:Kidney / Q000187:drug effects / Q000201:enzymology; D008168:Lung / Q000187:drug effects / Q000201:enzymology; D010105:Oxygenases / Q000235:genetics* / Q000378:metabolism; D049590:Postpartum Period / Q000378:metabolism; D011247:Pregnancy; D011270:Pregnancy, Animal / Q000378:metabolism*; D011374:Progesterone / Q000008:administration & dosage / Q000494:pharmacology; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D011817:Rabbits; D001743:Urinary Bladder / Q000201:enzymology; D015262:Xenobiotics / Q000378:metabolism
chemical_list: D005415:Flavins; D012333:RNA, Messenger; D015262:Xenobiotics; D011374:Progesterone; D003907:Dexamethasone; D010105:Oxygenases; C020066:dimethylaniline monooxygenase (N-oxide forming)